Diabetes Mellitus Clinical Trial
Official title:
Effect of Apple Cider Vinegar in Type 2 Diabetic Patients With Poor Glycemic Control: a Randomized Controlled Design
Background: apple cider vinegar is natural traditional health beneficial nutraceutical used
for many aliments. Diabetes mellitus (DM) has been considered a globally major health problem
and posing health burden on families and health system. Diabetes is associated with life
style that leading to reduce physical activities and increased in obesity. For development of
diabetes the known mechanism are endocrine disorders which cause impaired insulin secretion,
hepatic glucose over production and insulin resistance.
Objective: The aim of current randomized controlled trial was to investigate the effect of
apple cider vinegar on glycemic control and biochemical parameters in type 2 diabetic
patients with poor glycaemic control.
Material & Methods: 110 type 2 diabetic patients according to inclusion criteria were
selected and divided into two groups. Interventional group was given 15 ml apple cider
vinegar in 200ml water during meal at night time for 3 months. Before and after HbA1C,
fasting lipid profile, fasting blood sugar, anthropometrics and dietary changes were assessed
and analyzed using IBM SPSS version 20 through paired sample T-test where needed.
A study conducted in pre-diabetic healthy individuals showed significant (p=0.05) reduction
in HbA1C, in apple cider vinegar group . Many RCTs of human and animals showed hypolipidemic
effects of ACV. Anti obesity effect of apple cider vinegar also found in many studies. There
is still lot of work going on and this present study is conducted with an objective to
measure the effect of apple cider vinegar on HbA1c, fasting blood glucose, fasting lipid
profile and body weight.
METHOD:
STUDY DESIGN AND SETTING
This study was a single-blind, randomized-controlled placebo trial. Trial period was three
months from August 15, to November 15, 2017. This study was conducted at a 1050 beded
tertiary care, teaching hospital of Lahore, Pakistan. This hospital has high diabetics
out-patient turnover as being a reputable center in management of diabetes.
PARTICIPANTS:
Adult patients having type 2 diabetes, of both genders with age range from 30-60 years were
included. All having BMI between 20-30, non smoker and non alcoholics and all were on
standard medical therapy for diabetes (including Metformin + Sitagliptin group). Patients
suffering from known chronic renal disease and history of cardiovascular diseases like
stroke, ischemic heart disease and known allergy or intolerance to vinegar, reported by the
patient or relative and any kind of acute infection were excluded from study.
The sample size of 110 (55 in each group) was estimated by using 95% confidence level,80%
power with expected mean change in HbA1c 0.53% and 0.11% for cases treated with apple vinegar
and placebo respectively with a SD of 0.77% (by using power + precision 3.0 software).
Assuming a 12.6% non-response rate, RCT started with 126 patients, 63 patients in each group.
16 patients were lost to follow up during study period, so finally statistical analysis was
done on 110 patients 55 in each group.
DEPENDENT VARIABLES: A structured questionnaire was used for collecting respondents'
information. Blood samples were taken for biochemical test (HbA1c, lipid profile and fasting
blood glucose) and anthropometrics measurements were done.
Anthropometric measurements: Height was measured in centimeter to nearest 0.1 cm by using
standard stadiometer before intervention and weight was measured in kilogram to nearest 100 g
with wearing light cloth by using a calibrated weighing scale machine before and after
intervention. Hip/waist ratio and mid upper arm were measured with measuring tape in
centimeter to nearest 0.1cm. The BMI of study participants were classified as underweight,
normal, over weight and obese according to WHO criteria weight was measured as weight
(kg)/height (cm)2.
Biochemical assessments:
At before start of intervention and after intervention 5ml venous blood sample was taken with
12hours fasting for biochemical assessments including blood sugar fasting, HbA1C (glycated
hemoglobin), total cholesterol, low density lipoprotein, high density lipoprotein and
triglyceride were evaluated.
CONFOUNDING VARIABLES:
Dietary intake:
Diet of study participants can influence and confound the intervention during study period so
it was assessed through food frequency questionnaire. Food frequency was filled two times
before and after intervention to measure change during study period which can actually
confound the effect of apple cider vinegar. The food frequency questionnaire was structured
according to Pakistan's cultural food preferences and choices. FFQs contained methods of food
preparation, frequency per day and per week and portion size/ amount of food consumed in
categories from never, monthly to 1-7 days in a week. Food exchange lists were used to assess
the portion size of food. FFQ composed of cereal group, fruits, vegetable, meat, milk,
fat/oil, snacks and beverages.
INDEPENDENT VARIABLE/ INTERVENTION: This selected nutraceutical (Apple cider vinegar) was
given for three months. Apple cider vinegar was provided to patients and instructions were
given to all participants about the uses of apple cider vinegar and strictly follow the
prescribed nutraceutical given as per following schedule; Group I: Intervention group
Intervention group taking their diet according to their original meal pattern only dietary
guideline were given regarding high glycaemic and low glycaemic diet. Medical treatments
continued (including Metformin + Sitagliptin group). 15ml apple cider vinegar (American
garden organic vinegar) (containing 5% acetic acid) mixed in 200ml water during meal at night
time was prescribed.
Group II: comparison group Control group also taking their diet according to their original
meal pattern only dietary guideline were given regarding high glycaemic and low glycaemic
diet. Medical treatment continued (including Metformin + Sitagliptin group). 15ml apple cider
vinegar (flavor of ACV in plan water was used as placebo) mixed in 200ml plain water during
meal at night time.
Statistical analysis:
Descriptive statistical analysis was done for demographic profile, categorical and numerical
variables by measuring frequency, percentage, mean and standard deviation of all samples.
Paired sample T test was used for anthropometrics measurement and biochemical assessment for
two time assessment before and after intervention. Independent sample t-test was used for
comparison between groups. Where needed ANOVA was also applied. McNemar statistical test was
used to assess the food frequency questionnaire before and after intervention.
Ethical considerations:
Proper ethical clearance was obtained from Institutional Review Board of Shaikh Zayed Medical
Complex before starting the trial.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |